Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188834 · ClinicalTrials.gov registry record · NA
Effects of Sensory Flicker and Electrical Flicker Stimulation
A NA study of Brain Diseases, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT04188834: Completed NA study of Brain Diseases, sponsored by Emory University.
NCT04188834 is a NA study of Brain Diseases that has completed, run by Emory University. The registered enrollment target is 23 participants, below the 6,016-participant average among 12 other Brain Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04188834, a NA study of Brain Diseases, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate whether sensory flicker can modulate neural activity of deep brain regions in humans, and whether it can have relevant effects on behavior. Moreover, it will compare those effects to the gold-standard method of modulating brain circuits, direct electrical stimulation of the brain (the same mechanism as deep brain stimulation), using a powerful within-subjects design.
Primary Outcome
The power spectral density of the LFP will be measured across stimulus frequencies and modalities of sensory flicker stimuli in visual areas, auditory areas, hippocampus, and prefrontal cortex. To evaluate the effects of sensory flicker on brain activity in various brain regions, researchers compared the average increase in oscillatory neural activity of given recorded brain regions during sensory stimulation, among the total number of recording locations that showed a significant response to se
Conditions Studied
Interventions
- DEVICE Customized version of DAVID device
- DEVICE Blackrock CereStim
Study Locations (1)
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2022-11-22 |
| Phase | NA |
What the finished NCT04188834 record still lists
NCT04188834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 6,016-participant average among 12 other Brain Diseases trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Brain Diseases appearing as the primary indexed condition, and to 2 interventions - of which Customized version of DAVID device is the first listed.
NCT04188834 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04188834 about?
NCT04188834 is a clinical study titled "Effects of Sensory Flicker and Electrical Flicker Stimulation". The study will evaluate whether sensory flicker can modulate neural activity of deep brain regions in humans, and whether it can have relevant effects on behavior. Moreover, it will compare those effects to the gold-standard method of modulating brain circuits, direct electrical stimulation of the b...
What is the current status of trial NCT04188834?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-01-10. Estimated completion is 2022-11-22.
What conditions does trial NCT04188834 study?
This clinical trial studies the following conditions: Brain Diseases.
What interventions are being tested in trial NCT04188834?
The interventions under investigation include: Customized version of DAVID device (DEVICE), Blackrock CereStim (DEVICE).
Who is sponsoring clinical trial NCT04188834?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04188834 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04188834's enrollment target sits among peer trials
23 13th of 12 the lowest of 12 other Brain Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
RECRUITING · NA
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
ACTIVE NOT RECRUITING · NA
-
pRESET for Occlusive Stroke Treatment
COMPLETED · NA
-
Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI